Dirckx Naomi, Van Hul Matthias, Maes Christa
are from the Laboratory of Skeletal Cell Biology and Physiology (SCEBP), Skeletal Biology and Engineering Research Center (SBE), Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Birth Defects Res C Embryo Today. 2013 Sep;99(3):170-91. doi: 10.1002/bdrc.21047.
During endochondral bone development, bone-forming osteoblasts have to colonize the regions of cartilage that will be replaced by bone. In adulthood, bone remodeling and repair require osteogenic cells to reach the sites that need to be rebuilt, as a prerequisite for skeletal health. A failure of osteoblasts to reach the sites in need of bone formation may contribute to impaired fracture repair. Conversely, stimulation of osteogenic cell recruitment may be a promising osteo-anabolic strategy to improve bone formation in low bone mass disorders such as osteoporosis and in bone regeneration applications. Yet, still relatively little is known about the cellular and molecular mechanisms controlling osteogenic cell recruitment to sites of bone formation. In vitro, several secreted growth factors have been shown to induce osteogenic cell migration. Recent studies have started to shed light on the role of such chemotactic signals in the regulation of osteoblast recruitment during bone remodeling. Moreover, trafficking of osteogenic cells during endochondral bone development and repair was visualized in vivo by lineage tracing, revealing that the capacity of osteoblast lineage cells to move into new bone centers is largely confined to undifferentiated osteoprogenitors, and coupled to angiogenic invasion of the bone-modeling cartilage intermediate. It is well known that the presence of blood vessels is absolutely required for bone formation, and that a close spatial and temporal relationship exists between osteogenesis and angiogenesis. Studies using genetically modified mouse models have identified some of the molecular constituents of this osteogenic-angiogenic coupling. This article reviews the current knowledge on the process of osteoblast lineage cell recruitment to sites of active bone formation in skeletal development, remodeling, and repair, considering the role of chemo-attractants for osteogenic cells and the interplay between osteogenesis and angiogenesis in the control of bone formation.
在软骨内骨发育过程中,形成骨的成骨细胞必须定殖于将被骨替代的软骨区域。在成年期,骨重塑和修复需要成骨细胞到达需要重建的部位,这是骨骼健康的先决条件。成骨细胞无法到达需要形成骨的部位可能导致骨折修复受损。相反,刺激成骨细胞募集可能是一种有前景的骨合成代谢策略,可改善骨质疏松等低骨量疾病中的骨形成以及骨再生应用中的骨形成。然而,对于控制成骨细胞募集到骨形成部位的细胞和分子机制,人们仍然知之甚少。在体外,已显示几种分泌的生长因子可诱导成骨细胞迁移。最近的研究已开始揭示此类趋化信号在骨重塑过程中调节成骨细胞募集的作用。此外,通过谱系追踪在体内观察到软骨内骨发育和修复过程中成骨细胞的迁移,结果表明成骨细胞谱系细胞迁移到新骨中心的能力在很大程度上局限于未分化的骨祖细胞,并且与骨建模软骨中间体的血管生成性侵入相关。众所周知,血管的存在是骨形成绝对必需的,并且骨生成与血管生成之间存在密切的空间和时间关系。使用基因修饰小鼠模型的研究已经确定了这种骨生成 - 血管生成偶联的一些分子成分。本文综述了关于成骨细胞谱系细胞募集到骨骼发育、重塑和修复中活跃骨形成部位这一过程的当前知识,同时考虑了成骨细胞趋化因子的作用以及骨生成与血管生成在控制骨形成中的相互作用。